biotech

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025

By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck

from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck

Pevita Pearce August 4, 2025

In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent billions...